Funding round-up: Genocea, Depomed

Infectious disease company Genocea Biosciences Inc. (NASDAQ:GNCA) raised $45 million through the sale of 5.5 million shares at $8.25 in a follow-on underwritten by Cowen; Piper Jaffray; Stifel; and Needham. Genocea proposed the offering after market Wednesday when its shares closed at $8.48. The company added $0.63 to $9.11 on Thursday. Last July, Genocea withdrew a proposed $50.6 million follow-on, citing market conditions. The company raised $66 million in an IPO in February 2014 (see BioCentury Extra, July 16, 2014). ...